TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,955,000 | +17.2% | 2,019,400 | -15.9% | 0.32% | -27.2% |
| Q2 2022 | $10,200,000 | +3.7% | 2,400,000 | +132.0% | 0.43% | +45.2% |
| Q1 2022 | $9,840,000 | -54.8% | 1,034,663 | -9.7% | 0.30% | -72.2% |
| Q4 2021 | $21,774,000 | +13.5% | 1,146,000 | +98.9% | 1.08% | -26.7% |
| Q3 2021 | $19,176,000 | +23.6% | 576,200 | +44.0% | 1.47% | +73.2% |
| Q2 2021 | $15,516,000 | – | 400,000 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |